Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2025-01-31 00:00:00 ET · period of report 2025-01-31 · accession 0001823239-25-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-31 | 2025-01-31 | MRVI | ORESHACK KURT | GC | S - Sale | $5.03 | -25.0K | 167.6K | -13% | -$125.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-01-31 | S | D | 25,000 | $5.03 | 167,618 | D | — | — | (F1) The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024. |